Posts

Targeted protein degradation enabling technologies market

  Targeted protein degradation (TPD) is considered to be a transformative approach to selectively eliminate disease-causing proteins; over time, this upcoming class of small molecules has generated significant enthusiasm within the medical community   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Targeted Protein Degradation Market, 2021-2030 . ”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the current market landscape of drug developers engaged in the development of targeted protein degradation-based therapeutics.  §   An overview of the overall landscape of target protein degradation enabling te...

Patient Recruitment and Retention Services, 2019-2030

  To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Inclusions §   A detailed assessment of the current market landscape, including information on drug developer(s), §   A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient recruitment (including pre-screening and Institutional Review Board (IRB) / Ethics Committee (EC) submission), [B] patient retention (considering various strategies, such as the use of study-branded gifts, study-branded reminders, providing education and support materials, reimbursement programs, transportation programs, patient engagement web site, patient reconnect programs, mobile applications to track patient engagement...

The RNA targeting small molecules therapeutics market is estimated to be worth USD 8.3 billion in 2030.

  In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, “ RNA Targeting Small Molecules Therapeutics Market ”   The report features an extensive study of the current market landscape and future potential of the players engaged in the discovery and development of RNA targeting small molecules therapeutics. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:   §   An in-depth review of the market landscape of players that are engaged in the discovery and development of RNA targeting small molecules therapeutics being evaluated at both preclinical and clinical stag...